Study rebuts conflict fears around FDA
Financial ties of panels failed to sway decisions
A consumer group's study of Food and Drug Administration advisory panel members with financial ties to the drug industry reached a surprising conclusion: They did not dramatically sway the meeting outcomes. (Full article: 799 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
